GlassScriptPhysician profile
Nina Appareddy
NPI 1740818095
$4,201.35
in general payments reported to CMS, 2019-2025
8 companies · $3,038 in 2025
The $3,038 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $91.06 · 2024: $1,073 · 2025: $3,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,890 · Food and Beverage: $657 · Travel and Lodging: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,889.74 |
| Food and Beverage | $657.19 |
| Travel and Lodging | $654.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,902.40 | 2025 | Micra |
| Abiomed | $892.22 | 2023-2024 | Impella |
| Abbott Laboratories | $295.38 | 2024-2025 | Ensite, Mitraclip, Viewmate |
| Teleflex LLC | $34.70 | 2025 | Guideliner |
| Pfizer INC. | $24.85 | 2024 | |
| Boston Scientific Corporation | $19.95 | 2024 | Watchman Access System |
| Philips North America LLC | $18.16 | 2024 | (Br0) Coronary Atherectomy |
| Amgen INC. | $13.69 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Appareddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.